Maxus Realty Trust, Inc.
MRTI
$70.00
-$12.00-14.63%
| Weiss Ratings | MRTI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Unrated | |||
| Risk Index | Unrated | |||
| Risk Grade | U | |||
| Reward Grade | U | |||
| Rating Factors | MRTI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | Unrated | |||
| Growth Index | Unrated | |||
| Efficiency Index | Unrated | |||
| Solvency Index | Unrated | |||
| Total Return Index | Unrated | |||
| Volatility Index | Unrated | |||
| Beta / Standard Deviation | MRTI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.14 | |||
| Price History | MRTI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -14.63% | |||
| 30-Day Total Return | -12.50% | |||
| 60-Day Total Return | -6.67% | |||
| 90-Day Total Return | 0.00% | |||
| Year to Date Total Return | 8.95% | |||
| 1-Year Total Return | -2.44% | |||
| 2-Year Total Return | -37.88% | |||
| 3-Year Total Return | 42.06% | |||
| 5-Year Total Return | 90.07% | |||
| 52-Week High % Change | -17.62% | |||
| 52-Week Low % Change | 22.81% | |||
| Price | MRTI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $84.97 | |||
| 52-Week Low Price | $57.00 | |||
| 52-Week Low Price (Date) | Sep 05, 2024 | |||
| 52-Week High Price (Date) | Jan 10, 2025 | |||
| Valuation | MRTI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 83.15M | |||
| Enterprise Value | -- | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -- | |||
| Earnings Per Share Growth | -- | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | -- | |||
| Price/Book (Q) | -- | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | $70.00 | |||
| Enterprise Value/EBITDA (TTM) | -- | |||
| Enterprise Value/EBIT | -- | |||
| Market Cap Category | Micro Cap | |||
| Dividends and Shares | MRTI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | -- | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | $17.00 | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | $17.00 | |||
| Company Info | MRTI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 816 303 4500 | |||
| Address | 104 Armour Road North Kansas City, MO 64116-3503 | |||
| Website | www.mrti.com | |||
| Country | United States | |||
| Year Founded | -- | |||
| Profitability | MRTI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 22.54% | |||
| Profit Margin | -3.78% | |||
| Management Effectiveness | MRTI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 2.22% | |||
| Return on Equity | -- | |||
| Income Statement | MRTI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 24.62M | |||
| Total Revenue (TTM) | 27.63M | |||
| Revenue Per Share | -- | |||
| Gross Profit (TTM) | 18.73M | |||
| EBITDA (TTM) | 13.34M | |||
| EBIT (TTM) | 6.23M | |||
| Net Income (TTM) | -1.05M | |||
| Net Income Avl. to Common (TTM) | -1.05M | |||
| Total Revenue Growth (Q YOY) | 36.34% | |||
| Earnings Growth (Q YOY) | -1,125.00% | |||
| EPS Diluted (TTM) | -0.85 | |||
| EPS Diluted Growth (Q YOY) | -1,332.99% | |||
| Balance Sheet | MRTI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 3.07M | |||
| Cash Per Share (Q) | $2.49 | |||
| Total Current Assets (Q) | 7.27M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 16.12M | |||
| Current Ratio (Q) | 0.560 | |||
| Book Value Per Share (Q) | -- | |||
| Total Assets (Q) | -- | |||
| Total Current Liabilities (Q) | 12.98M | |||
| Total Debt (Q) | -- | |||
| Total Liabilities (Q) | -- | |||
| Total Common Equity (Q) | 6.91M | |||
| Cash Flow | MRTI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -18.37M | |||
| Cash from Financing (TTM) | 13.25M | |||
| Net Change in Cash (TTM) | 1.77M | |||
| Levered Free Cash Flow (TTM) | 28.52M | |||
| Cash from Operations (TTM) | 6.89M | |||
